These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Prospective evaluation of kidney and liver disease in autosomal recessive polycystic kidney disease-congenital hepatic fibrosis. Abdul Majeed N; Font-Montgomery E; Lukose L; Bryant J; Veppumthara P; Choyke PL; Turkbey IB; Heller T; Gahl WA; Gunay-Aygun M Mol Genet Metab; 2020; 131(1-2):267-276. PubMed ID: 32919899 [TBL] [Abstract][Full Text] [Related]
13. Clinical and molecular characterization defines a broadened spectrum of autosomal recessive polycystic kidney disease (ARPKD). Adeva M; El-Youssef M; Rossetti S; Kamath PS; Kubly V; Consugar MB; Milliner DM; King BF; Torres VE; Harris PC Medicine (Baltimore); 2006 Jan; 85(1):1-21. PubMed ID: 16523049 [TBL] [Abstract][Full Text] [Related]
14. Hypomagnesaemia is absent in children with autosomal dominant polycystic kidney disease. Seeman T; Fořtová M; Sopko B; Průša R; Pohl M; John U Ann Clin Biochem; 2019 Jan; 56(1):90-94. PubMed ID: 29874928 [TBL] [Abstract][Full Text] [Related]
15. Long-term outcome of transjugular intrahepatic portosystemic shunt for portal hypertension in autosomal recessive polycystic kidney disease. Verbeeck S; Mekhali D; Cassiman D; Maleux G; Witters P Dig Liver Dis; 2018 Jul; 50(7):707-712. PubMed ID: 29622386 [TBL] [Abstract][Full Text] [Related]
16. Neurocognition in children with autosomal recessive polycystic kidney disease in the CKiD cohort study. Hartung EA; Matheson M; Lande MB; Dell KM; Guay-Woodford LM; Gerson AC; Warady BA; Hooper SR; Furth SL Pediatr Nephrol; 2014 Oct; 29(10):1957-65. PubMed ID: 24828609 [TBL] [Abstract][Full Text] [Related]
17. Initial evaluation of hepatic T1 relaxation time as an imaging marker of liver disease associated with autosomal recessive polycystic kidney disease (ARPKD). Gao Y; Erokwu BO; DeSantis DA; Croniger CM; Schur RM; Lu L; Mariappuram J; Dell KM; Flask CA NMR Biomed; 2016 Jan; 29(1):84-9. PubMed ID: 26608869 [TBL] [Abstract][Full Text] [Related]
18. Association of urinary biomarkers with disease severity in patients with autosomal dominant polycystic kidney disease: a cross-sectional analysis. Meijer E; Boertien WE; Nauta FL; Bakker SJ; van Oeveren W; Rook M; van der Jagt EJ; van Goor H; Peters DJ; Navis G; de Jong PE; Gansevoort RT Am J Kidney Dis; 2010 Nov; 56(5):883-95. PubMed ID: 20888104 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of liver-type fatty acid binding protein (L-FABP) and interleukin 6 in children with renal cysts. Plesiński K; Adamczyk P; Świętochowska E; Morawiec-Knysak A; Gliwińska A; Korlacki W; Szczepańska M Adv Clin Exp Med; 2019 Dec; 28(12):1675-1682. PubMed ID: 31778601 [TBL] [Abstract][Full Text] [Related]
20. Transient Elastography for Detection of Liver Fibrosis in Children With Autosomal Recessive Polycystic Kidney Disease. Wicher D; Jankowska I; Lipiński P; Szymańska-Rożek P; Kmiotek J; Jańczyk W; Rubik J; Chrzanowska K; Socha P Front Pediatr; 2018; 6():422. PubMed ID: 30687687 [No Abstract] [Full Text] [Related] [Next] [New Search]